Company intelligence / Profile preview

Brightseed

California, United Statesbrightseedbio.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Brightseed has discovered bioactive compounds NCT and NFT that have been shown in pre-clinical studies to support gut health. They have developed proprietary ingredients from hemp hull for gut health applications.[3]

Therapeutic areas: GastroenterologyMetabolic Disorders
Modalities: Bioactive compoundsnatural ingredients
Industry: Non-Drug Biotech

Drug pipeline

1 asset

Bio Gut Fiber

Commercial

Indications: Gut health, Digestive health

Partnerships

Industry leaders in food, beverage, and supplement industries[1][5]

Beyond the preview

Go deeper on Brightseed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brightseed.

Explore the full profile